• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Reimagine Care, DispatchHealth Partner for Home Oncology  Care.

Share:

July 25, 2023

Reimagine Care, a home-based cancer care platform, has partnered with DispatchHealth, an in-home care provider, to offer virtual-to-home care for oncology patients. Reimagine’s clinicians will remotely monitor patients and coordinate with oncologists to determine additional services required, while DispatchHealth allows patients to request in-home urgent care visits. The collaboration aims to improve the cancer care experience for patients and their families by providing coordinated care and support. Reimagine Care recently appointed Dan Nardi as its CEO and secured $25 million in Series A funding. DispatchHealth raised $330 million in funding last year.

Home-based cancer care platform Reimagine Care announced it is partnering with in-home care provider DispatchHealth to provide virtual-to-home care for oncology patients.

Reimagine Care partners with providers and health plans to coordinate care in the home to avoid unnecessary inpatient visits. Reimagine clinicians can remotely monitor patients, work with oncologists to determine whether patients need additional services and send home care workers to assist.

Denver-based DispatchHealth allows patients to request an in-home urgent care medical visit via telephone or the company’s app or website. The care team includes a physician assistant or nurse practitioner and/or a medical technician. Care teams are remotely supported by an emergency medicine physician if needed.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Through the collaboration, cancer patients will have access to virtual-to-home care as well as coordinated care between Reimagine Care, DispatchHealth and the patient’s primary oncology care team.

“Supporting patients virtually, through our experienced oncology clinicians, and in the home, through this partnership with DispatchHealth, will alleviate many of the triage and symptom management demands on clinicians while improving the cancer care experience for patients and their families,” Dr. Pallav Mehta, medical director for Reimagine Care, said in a statement.

THE LARGER TREND

Earlier this month, Reimagine Care announced the appointment of Dan Nardi as its new CEO. Nardi previously held the position of chief operating officer at employer-focused specialty care platform Carrum Health.

Last year, Reimagine scored $25 million in Series A funding. It also announced a partnership with complex care management platform Memora Health. Reimagine would leverage Memora’s clinical intelligence platform to scale its virtual care center to support cancer patients and caregivers at home.

DispatchHealth has also established several partnerships. Last month, the company said Georgia-based healthcare system Emory Healthcare would incorporate DispatchHealth’s Acute Care, Bridge Care and ED-to-Home programs into its offerings.

The company also established partnerships with Blue Shield of California, Oklahoma’s Saint Francis Health System, Marshfield Clinic Health System and California-based virtual care company Included Health, which provides healthcare benefits and insurance navigation services, as well as virtual primary care, behavioral health, specialty care and 24/7 urgent care appointments.

DispatchHealth raised $330 million in funding in November, bringing its total raise to over $700 million. The company scored $200 million in Series D financing a year prior.

Source: MobihealthNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • BioIVT Acquires PPA Research Group, Increasing its Ability to Support Drug Development, Cell and Gene Therapy ResearchBioIVT Acquires PPA Research Group, Increasing its Ability to Support Drug Development, Cell and Gene Therapy Research
  • Civilized To Acquire Full-Service Marketing Communications Agency Revolution StrategyCivilized To Acquire Full-Service Marketing Communications Agency Revolution Strategy
  • Geyser Brands Inc. Announces Signing of Letter of Intent to Acquire Brands
  • Verily Launches Joint Venture to Develop & Commercialize Ophthalmic DevicesVerily Launches Joint Venture to Develop & Commercialize Ophthalmic Devices
  • Caris Life Sciences Raises $400M to Advance AI-Driven Molecular Profiling to Revolutionize Cancer CareCaris Life Sciences Raises $400M to Advance AI-Driven Molecular Profiling to Revolutionize Cancer Care
  • Sio Gene Therapies Announces Receipt of $11.6 Million from Closing of the Sale of Arvelle TherapeuticsSio Gene Therapies Announces Receipt of $11.6 Million from Closing of the Sale of Arvelle Therapeutics
  • Healthcare Blockchain Startup BurstIQ Nabs $5.5M for Hipaa-Compliant Blockchain PlatformHealthcare Blockchain Startup BurstIQ Nabs $5.5M for Hipaa-Compliant Blockchain Platform
  • Foamix Pharm And Menlo Therapeutics To Merge – Quick FactsFoamix Pharm And Menlo Therapeutics To Merge – Quick Facts

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications